Two common drugs face off to stop dangerous procedure complication
NCT ID NCT06252441
Summary
This study tested whether an oral antioxidant (N-Acetyl cysteine) or a rectal anti-inflammatory drug (diclofenac) is better at preventing pancreatitis, a painful and serious complication that can occur after an ERCP procedure. The trial involved 46 adult patients undergoing ERCP for bile or pancreatic duct issues. Researchers compared how well each drug prevented inflammation and pancreatitis after the procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-ERCP PANCREATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Obstructive Jaundice Clinic in the National Liver Institute, Menoufia University , Shebin Elkoom
Menofia, Egypt
Conditions
Explore the condition pages connected to this study.